Anti-thyroid peroxidase antibody positivity-GO
May 23, 2022Anti-thyroid peroxidase antibody positivity (HP:0025379) -GO
GO: Biological Process
| Index | Name | P-value | Adjusted p-value | Odds Ratio | Combined score |
| 1 | negative regulation of neurotransmitter secretion (GO:0046929) | 0.000004719 | 0.0002463 | 999.25 | 12254.80 |
| 2 | regulation of phospholipase C activity (GO:1900274) | 4.082e-8 | 0.000005327 | 713.50 | 12139.53 |
| 3 | negative regulation of regulated secretory pathway (GO:1903306) | 0.000006290 | 0.0002736 | 832.67 | 9972.50 |
| 4 | Rap protein signal transduction (GO:0032486) | 0.00001010 | 0.0003767 | 624.44 | 7182.69 |
| 5 | positive regulation of integrin activation (GO:0033625) | 0.00001235 | 0.0004028 | 555.03 | 6273.06 |
| 6 | Ras protein signal transduction (GO:0007265) | 2.362e-11 | 6.166e-9 | 218.98 | 5358.13 |
| 7 | microvillus organization (GO:0032528) | 0.00002041 | 0.0004160 | 416.21 | 4494.85 |
| 8 | regulation of integrin activation (GO:0033623) | 0.00002354 | 0.0004160 | 384.17 | 4094.01 |
| 9 | microvillus assembly (GO:0030033) | 0.00002354 | 0.0004160 | 384.17 | 4094.01 |
| 10 | regulation of miRNA metabolic process (GO:2000628) | 0.002498 | 0.01207 | 555.17 | 3326.77 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 0.00003830 | 0.0005880 | 293.72 | 2987.15 |
| 12 | positive regulation of cell-cell adhesion mediated by integrin (GO:0033634) | 0.002997 | 0.01372 | 444.11 | 2580.41 |
| 13 | positive regulation of phospholipase activity (GO:0010518) | 0.00006174 | 0.0008057 | 226.91 | 2199.35 |
| 14 | negative regulation of T cell apoptotic process (GO:0070233) | 0.003495 | 0.01546 | 370.07 | 2093.27 |
| 15 | positive regulation of miRNA metabolic process (GO:2000630) | 0.003495 | 0.01546 | 370.07 | 2093.27 |
| 16 | small GTPase mediated signal transduction (GO:0007264) | 1.527e-7 | 0.00001193 | 129.99 | 2040.10 |
| 17 | endothelial cell development (GO:0001885) | 0.00007266 | 0.0008620 | 207.98 | 1981.99 |
| 18 | regulation of cell junction assembly (GO:1901888) | 0.00007845 | 0.0008902 | 199.65 | 1887.30 |
| 19 | positive regulation of adaptive immune response (GO:0002821) | 0.003994 | 0.01737 | 317.19 | 1751.86 |
| 20 | establishment of endothelial barrier (GO:0061028) | 0.00009070 | 0.0009469 | 184.84 | 1720.52 |
| 21 | positive regulation of leukocyte cell-cell adhesion (GO:1903039) | 0.0001038 | 0.0009677 | 172.08 | 1578.44 |
| 22 | cellular response to cAMP (GO:0071320) | 0.0001038 | 0.0009677 | 172.08 | 1578.44 |
| 23 | lipid phosphorylation (GO:0046834) | 0.004990 | 0.01944 | 246.68 | 1307.49 |
| 24 | nerve growth factor signaling pathway (GO:0038180) | 0.004990 | 0.01944 | 246.68 | 1307.49 |
| 25 | regulation of T-helper 17 type immune response (GO:2000316) | 0.004990 | 0.01944 | 246.68 | 1307.49 |
| 26 | regulation of cell-cell adhesion mediated by integrin (GO:0033632) | 0.004990 | 0.01944 | 246.68 | 1307.49 |
| 27 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 0.004990 | 0.01944 | 246.68 | 1307.49 |
| 28 | positive regulation of vasculogenesis (GO:2001214) | 0.004990 | 0.01944 | 246.68 | 1307.49 |
| 29 | response to cAMP (GO:0051591) | 0.0001567 | 0.001319 | 138.57 | 1214.06 |
| 30 | regulation of cellular component biogenesis (GO:0044087) | 0.0001651 | 0.001347 | 134.82 | 1174.13 |
| 31 | regulation of T cell apoptotic process (GO:0070232) | 0.005488 | 0.02046 | 222.00 | 1155.57 |
| 32 | glycerolipid metabolic process (GO:0046486) | 0.005488 | 0.02046 | 222.00 | 1155.57 |
| 33 | regulation of phospholipase activity (GO:0010517) | 0.005488 | 0.02046 | 222.00 | 1155.57 |
| 34 | positive regulation of phospholipase C activity (GO:0010863) | 0.0002010 | 0.001543 | 121.64 | 1035.45 |
| 35 | regulation of leukocyte cell-cell adhesion (GO:1903037) | 0.005985 | 0.02165 | 201.81 | 1032.95 |
| 36 | positive regulation of T-helper 17 type immune response (GO:2000318) | 0.005985 | 0.02165 | 201.81 | 1032.95 |
| 37 | MAPK cascade (GO:0000165) | 1.829e-7 | 0.00001193 | 66.08 | 1025.21 |
| 38 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824) | 0.006482 | 0.02169 | 184.98 | 932.06 |
| 39 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 0.006482 | 0.02169 | 184.98 | 932.06 |
| 40 | regulation of homotypic cell-cell adhesion (GO:0034110) | 0.006482 | 0.02169 | 184.98 | 932.06 |
| 41 | positive regulation of ruffle assembly (GO:1900029) | 0.006482 | 0.02169 | 184.98 | 932.06 |
| 42 | positive regulation of vascular endothelial cell proliferation (GO:1905564) | 0.006482 | 0.02169 | 184.98 | 932.06 |
| 43 | regulation of vasculogenesis (GO:2001212) | 0.006979 | 0.02277 | 170.74 | 847.70 |
| 44 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 0.006979 | 0.02277 | 170.74 | 847.70 |
| 45 | cellular response to lectin (GO:1990858) | 0.00002158 | 0.0004160 | 76.06 | 817.21 |
| 46 | stimulatory C-type lectin receptor signaling pathway (GO:0002223) | 0.00002158 | 0.0004160 | 76.06 | 817.21 |
| 47 | innate immune response activating cell surface receptor signaling pathway (GO:0002220) | 0.00002391 | 0.0004160 | 73.43 | 781.36 |
| 48 | T cell proliferation (GO:0042098) | 0.007476 | 0.02375 | 158.54 | 776.21 |
| 49 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 0.007476 | 0.02375 | 158.54 | 776.21 |
| 50 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 0.007973 | 0.02414 | 147.96 | 714.91 |
| 51 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 0.007973 | 0.02414 | 147.96 | 714.91 |
| 52 | regulation of establishment of cell polarity (GO:2000114) | 0.007973 | 0.02414 | 147.96 | 714.91 |
| 53 | cellular response to gamma radiation (GO:0071480) | 0.008469 | 0.02463 | 138.71 | 661.82 |
| 54 | positive regulation of telomere capping (GO:1904355) | 0.008469 | 0.02463 | 138.71 | 661.82 |
| 55 | regulation of cellular component organization (GO:0051128) | 0.00003804 | 0.0005880 | 62.57 | 636.72 |
| 56 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 0.008966 | 0.02463 | 130.54 | 615.43 |
| 57 | regulation of adaptive immune response (GO:0002819) | 0.008966 | 0.02463 | 130.54 | 615.43 |
| 58 | regulation of vascular endothelial cell proliferation (GO:1905562) | 0.008966 | 0.02463 | 130.54 | 615.43 |
| 59 | positive regulation of interleukin-4 production (GO:0032753) | 0.008966 | 0.02463 | 130.54 | 615.43 |
| 60 | regulation of platelet aggregation (GO:0090330) | 0.008966 | 0.02463 | 130.54 | 615.43 |
| 61 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 0.008966 | 0.02463 | 130.54 | 615.43 |
| 62 | positive regulation of hydrolase activity (GO:0051345) | 0.00004680 | 0.0006786 | 58.25 | 580.74 |
| 63 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 0.009462 | 0.02546 | 123.28 | 574.57 |
| 64 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 0.009462 | 0.02546 | 123.28 | 574.57 |
| 65 | positive regulation of MAP kinase activity (GO:0043406) | 0.0005185 | 0.003561 | 74.34 | 562.35 |
| 66 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 0.009957 | 0.02652 | 116.79 | 538.34 |
| 67 | T cell receptor signaling pathway (GO:0050852) | 0.00005573 | 0.0007656 | 54.84 | 537.19 |
| 68 | positive regulation of JNK cascade (GO:0046330) | 0.0005802 | 0.003883 | 70.14 | 522.67 |
| 69 | neurotrophin signaling pathway (GO:0038179) | 0.01045 | 0.02708 | 110.94 | 506.01 |
| 70 | positive regulation of endothelial cell proliferation (GO:0001938) | 0.0006453 | 0.004211 | 66.38 | 487.64 |
| 71 | positive regulation of ERK1 and ERK2 cascade (GO:0070374) | 0.00007175 | 0.0008620 | 50.26 | 479.64 |
| 72 | cellular response to nerve growth factor stimulus (GO:1990090) | 0.01095 | 0.02708 | 105.66 | 476.99 |
| 73 | regulation of platelet activation (GO:0010543) | 0.01095 | 0.02708 | 105.66 | 476.99 |
| 74 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 75 | regulation of interleukin-4 production (GO:0032673) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 76 | regulation of telomere capping (GO:1904353) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 77 | membrane protein ectodomain proteolysis (GO:0006509) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 78 | negative regulation of GTPase activity (GO:0034260) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 79 | positive regulation of epithelial cell apoptotic process (GO:1904037) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 80 | diacylglycerol metabolic process (GO:0046339) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 81 | positive regulation of interleukin-17 production (GO:0032740) | 0.01144 | 0.02708 | 100.85 | 450.83 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 0.00008908 | 0.0009469 | 46.64 | 435.00 |
| 83 | regulation of ruffle assembly (GO:1900027) | 0.01194 | 0.02733 | 96.46 | 427.12 |
| 84 | positive regulation of protein targeting to membrane (GO:0090314) | 0.01194 | 0.02733 | 96.46 | 427.12 |
| 85 | response to gamma radiation (GO:0010332) | 0.01194 | 0.02733 | 96.46 | 427.12 |
| 86 | regulation of GTPase activity (GO:0043087) | 0.00009492 | 0.0009528 | 45.63 | 422.66 |
| 87 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 0.01243 | 0.02797 | 92.44 | 405.55 |
| 88 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 0.01243 | 0.02797 | 92.44 | 405.55 |
| 89 | positive regulation of protein phosphorylation (GO:0001934) | 0.00002240 | 0.0004160 | 35.65 | 381.65 |
| 90 | positive regulation of calcium ion transmembrane transport (GO:1904427) | 0.01342 | 0.02944 | 85.32 | 367.79 |
| 91 | cellular senescence (GO:0090398) | 0.01342 | 0.02944 | 85.32 | 367.79 |
| 92 | negative regulation of insulin receptor signaling pathway (GO:0046627) | 0.01342 | 0.02944 | 85.32 | 367.79 |
| 93 | regulation of MAP kinase activity (GO:0043405) | 0.001021 | 0.006502 | 52.36 | 360.55 |
| 94 | positive regulation of protein modification process (GO:0031401) | 0.0001371 | 0.001193 | 40.17 | 357.33 |
| 95 | positive regulation of GTPase activity (GO:0043547) | 0.0001371 | 0.001193 | 40.17 | 357.33 |
| 96 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 0.01392 | 0.02977 | 82.15 | 351.18 |
| 97 | positive regulation of response to wounding (GO:1903036) | 0.01392 | 0.02977 | 82.15 | 351.18 |
| 98 | cellular response to epidermal growth factor stimulus (GO:0071364) | 0.01392 | 0.02977 | 82.15 | 351.18 |
| 99 | positive regulation of stress-activated MAPK cascade (GO:0032874) | 0.001064 | 0.006610 | 51.27 | 351.00 |
| 100 | regulation of protein targeting to membrane (GO:0090313) | 0.01441 | 0.03033 | 79.21 | 335.86 |
| 101 | cellular response to organonitrogen compound (GO:0071417) | 0.001151 | 0.006983 | 49.23 | 333.17 |
| 102 | regulation of JNK cascade (GO:0046328) | 0.001195 | 0.007064 | 48.27 | 324.82 |
| 103 | positive regulation of small GTPase mediated signal transduction (GO:0051057) | 0.01490 | 0.03063 | 76.48 | 321.69 |
| 104 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 0.01490 | 0.03063 | 76.48 | 321.69 |
| 105 | positive regulation of lipid kinase activity (GO:0090218) | 0.01490 | 0.03063 | 76.48 | 321.69 |
| 106 | positive regulation of protein serine/threonine kinase activity (GO:0071902) | 0.001218 | 0.007064 | 47.80 | 320.79 |
| 107 | regulation of ERK1 and ERK2 cascade (GO:0070372) | 0.0001877 | 0.001485 | 36.03 | 309.13 |
| 108 | Fc-epsilon receptor signaling pathway (GO:0038095) | 0.001334 | 0.007542 | 45.60 | 301.83 |
| 109 | Fc receptor signaling pathway (GO:0038093) | 0.001358 | 0.007542 | 45.18 | 298.27 |
| 110 | activation of phospholipase C activity (GO:0007202) | 0.01589 | 0.03190 | 71.54 | 296.32 |
| 111 | B cell proliferation (GO:0042100) | 0.01589 | 0.03190 | 71.54 | 296.32 |
| 112 | positive regulation of telomere maintenance (GO:0032206) | 0.01589 | 0.03190 | 71.54 | 296.32 |
| 113 | regulation of interleukin-17 production (GO:0032660) | 0.01638 | 0.03239 | 69.30 | 284.93 |
| 114 | positive regulation of telomere maintenance via telomerase (GO:0032212) | 0.01638 | 0.03239 | 69.30 | 284.93 |
| 115 | positive regulation of phosphorylation (GO:0042327) | 0.0002248 | 0.001676 | 33.84 | 284.27 |
| 116 | positive regulation of protein-containing complex assembly (GO:0031334) | 0.001506 | 0.007802 | 42.83 | 278.34 |
| 117 | positive regulation of calcium ion transport into cytosol (GO:0010524) | 0.01687 | 0.03262 | 67.20 | 274.29 |
| 118 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 0.01687 | 0.03262 | 67.20 | 274.29 |
| 119 | positive regulation of telomerase activity (GO:0051973) | 0.01687 | 0.03262 | 67.20 | 274.29 |
| 120 | regulation of protein phosphorylation (GO:0001932) | 0.0002605 | 0.001889 | 32.15 | 265.30 |
| 121 | regulation of T cell receptor signaling pathway (GO:0050856) | 0.01737 | 0.03309 | 65.22 | 264.33 |
| 122 | positive regulation of lymphocyte activation (GO:0051251) | 0.01737 | 0.03309 | 65.22 | 264.33 |
| 123 | positive regulation of epithelial cell proliferation (GO:0050679) | 0.001635 | 0.008204 | 41.05 | 263.40 |
| 124 | positive regulation of telomere maintenance via telomere lengthening (GO:1904358) | 0.01786 | 0.03378 | 63.35 | 255.00 |
| 125 | positive regulation of MAPK cascade (GO:0043410) | 0.0002842 | 0.002005 | 31.18 | 254.65 |
| 126 | regulation of actin cytoskeleton reorganization (GO:2000249) | 0.01835 | 0.03421 | 61.59 | 246.23 |
| 127 | regulation of p38MAPK cascade (GO:1900744) | 0.01835 | 0.03421 | 61.59 | 246.23 |
| 128 | lymphocyte proliferation (GO:0046651) | 0.01884 | 0.03488 | 59.92 | 237.98 |
| 129 | membrane protein proteolysis (GO:0033619) | 0.01933 | 0.03554 | 58.34 | 230.20 |
| 130 | positive regulation of wound healing (GO:0090303) | 0.01983 | 0.03618 | 56.84 | 222.86 |
| 131 | acylglycerol metabolic process (GO:0006639) | 0.02032 | 0.03682 | 55.42 | 215.92 |
| 132 | lipid modification (GO:0030258) | 0.02130 | 0.03756 | 52.77 | 203.13 |
| 133 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 0.02130 | 0.03756 | 52.77 | 203.13 |
| 134 | natural killer cell activation (GO:0030101) | 0.02130 | 0.03756 | 52.77 | 203.13 |
| 135 | cellular response to organic cyclic compound (GO:0071407) | 0.002417 | 0.01190 | 33.52 | 201.95 |
| 136 | positive regulation of cell-matrix adhesion (GO:0001954) | 0.02179 | 0.03756 | 51.54 | 197.22 |
| 137 | regulation of endothelial cell apoptotic process (GO:2000351) | 0.02179 | 0.03756 | 51.54 | 197.22 |
| 138 | regulation of insulin receptor signaling pathway (GO:0046626) | 0.02228 | 0.03756 | 50.37 | 191.61 |
| 139 | positive regulation of RNA metabolic process (GO:0051254) | 0.02228 | 0.03756 | 50.37 | 191.61 |
| 140 | cellular response to growth factor stimulus (GO:0071363) | 0.002677 | 0.01270 | 31.79 | 188.27 |
| 141 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 0.02277 | 0.03756 | 49.25 | 186.27 |
| 142 | regulation of telomerase activity (GO:0051972) | 0.02277 | 0.03756 | 49.25 | 186.27 |
| 143 | interleukin-12-mediated signaling pathway (GO:0035722) | 0.02277 | 0.03756 | 49.25 | 186.27 |
| 144 | epidermal growth factor receptor signaling pathway (GO:0007173) | 0.02326 | 0.03756 | 48.17 | 181.19 |
| 145 | positive regulation of cell-cell adhesion (GO:0022409) | 0.02326 | 0.03756 | 48.17 | 181.19 |
| 146 | regulation of T cell activation (GO:0050863) | 0.02326 | 0.03756 | 48.17 | 181.19 |
| 147 | regulation of wound healing (GO:0061041) | 0.02326 | 0.03756 | 48.17 | 181.19 |
| 148 | polyol metabolic process (GO:0019751) | 0.02326 | 0.03756 | 48.17 | 181.19 |
| 149 | cellular response to interleukin-12 (GO:0071349) | 0.02375 | 0.03756 | 47.15 | 176.34 |
| 150 | cellular response to ionizing radiation (GO:0071479) | 0.02375 | 0.03756 | 47.15 | 176.34 |
| 151 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 0.02375 | 0.03756 | 47.15 | 176.34 |
| 152 | phosphatidic acid biosynthetic process (GO:0006654) | 0.02375 | 0.03756 | 47.15 | 176.34 |
| 153 | inositol phosphate metabolic process (GO:0043647) | 0.02375 | 0.03756 | 47.15 | 176.34 |
| 154 | regulation of MAPK cascade (GO:0043408) | 0.002950 | 0.01372 | 30.22 | 176.08 |
| 155 | regulation of stress-activated MAPK cascade (GO:0032872) | 0.02424 | 0.03811 | 46.16 | 171.72 |
| 156 | phosphatidic acid metabolic process (GO:0046473) | 0.02473 | 0.03864 | 45.22 | 167.30 |
| 157 | regulation of epithelial cell migration (GO:0010632) | 0.02521 | 0.03917 | 44.31 | 163.08 |
| 158 | regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 0.02570 | 0.03946 | 43.44 | 159.04 |
| 159 | regulation of telomere maintenance via telomerase (GO:0032210) | 0.02570 | 0.03946 | 43.44 | 159.04 |
| 160 | regulation of megakaryocyte differentiation (GO:0045652) | 0.02668 | 0.04072 | 41.80 | 151.46 |
| 161 | regulation of blood vessel endothelial cell migration (GO:0043535) | 0.02717 | 0.04123 | 41.02 | 147.91 |
| 162 | positive regulation of interferon-gamma production (GO:0032729) | 0.02814 | 0.04246 | 39.55 | 141.22 |
| 163 | negative regulation of hydrolase activity (GO:0051346) | 0.02863 | 0.04295 | 38.86 | 138.07 |
| 164 | axon guidance (GO:0007411) | 0.004372 | 0.01871 | 24.61 | 133.71 |
| 165 | positive regulation of DNA biosynthetic process (GO:2000573) | 0.03009 | 0.04488 | 36.91 | 129.31 |
| 166 | positive regulation of Ras protein signal transduction (GO:0046579) | 0.03106 | 0.04607 | 35.71 | 123.99 |
| 167 | regulation of cell-matrix adhesion (GO:0001952) | 0.03204 | 0.04724 | 34.59 | 119.03 |
| 168 | ERBB signaling pathway (GO:0038127) | 0.03252 | 0.04769 | 34.06 | 116.68 |
| 169 | neutrophil degranulation (GO:0043312) | 0.001462 | 0.007802 | 17.49 | 114.20 |
| 170 | neutrophil activation involved in immune response (GO:0002283) | 0.001498 | 0.007802 | 17.35 | 112.81 |
| 171 | regulation of myeloid cell differentiation (GO:0045637) | 0.03349 | 0.04883 | 33.04 | 112.22 |
| 172 | neutrophil mediated immunity (GO:0002446) | 0.001524 | 0.007802 | 17.24 | 111.79 |
| 173 | cell chemotaxis (GO:0060326) | 0.03398 | 0.04927 | 32.55 | 110.09 |
| 174 | positive regulation of cell-substrate adhesion (GO:0010811) | 0.03446 | 0.04969 | 32.08 | 108.04 |
| 175 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 0.03495 | 0.05011 | 31.62 | 106.05 |
| 176 | axonogenesis (GO:0007409) | 0.006056 | 0.02165 | 20.75 | 105.95 |
| 177 | Fc-gamma receptor signaling pathway (GO:0038094) | 0.03543 | 0.05053 | 31.17 | 104.12 |
| 178 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 0.03640 | 0.05135 | 30.32 | 100.44 |
| 179 | regulation of peptide hormone secretion (GO:0090276) | 0.03640 | 0.05135 | 30.32 | 100.44 |
| 180 | positive regulation of T cell activation (GO:0050870) | 0.03688 | 0.05148 | 29.90 | 98.68 |
| 181 | positive regulation of immune response (GO:0050778) | 0.03688 | 0.05148 | 29.90 | 98.68 |
| 182 | positive regulation of tumor necrosis factor production (GO:0032760) | 0.03785 | 0.05227 | 29.11 | 95.32 |
| 183 | glycerophospholipid metabolic process (GO:0006650) | 0.03930 | 0.05398 | 28.00 | 90.64 |
| 184 | positive regulation of cell migration (GO:0030335) | 0.007553 | 0.02375 | 18.47 | 90.23 |
| 185 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 0.03978 | 0.05436 | 27.65 | 89.16 |
| 186 | positive regulation of cytoskeleton organization (GO:0051495) | 0.04026 | 0.05445 | 27.31 | 87.73 |
| 187 | ephrin receptor signaling pathway (GO:0048013) | 0.04026 | 0.05445 | 27.31 | 87.73 |
| 188 | positive regulation of plasma membrane bounded cell projection assembly (GO:0120034) | 0.04074 | 0.05481 | 26.98 | 86.34 |
| 189 | plasma membrane bounded cell projection assembly (GO:0120031) | 0.008048 | 0.02414 | 17.86 | 86.11 |
| 190 | B cell activation (GO:0042113) | 0.04171 | 0.05561 | 26.33 | 83.66 |
| 191 | regulation of Ras protein signal transduction (GO:0046578) | 0.04219 | 0.05561 | 26.02 | 82.37 |
| 192 | regulation of interferon-gamma production (GO:0032649) | 0.04219 | 0.05561 | 26.02 | 82.37 |
| 193 | positive regulation of endothelial cell migration (GO:0010595) | 0.04219 | 0.05561 | 26.02 | 82.37 |
| 194 | positive regulation of neuron projection development (GO:0010976) | 0.04315 | 0.05659 | 25.42 | 79.89 |
| 195 | second-messenger-mediated signaling (GO:0019932) | 0.04363 | 0.05694 | 25.13 | 78.70 |
| 196 | T cell activation (GO:0042110) | 0.04507 | 0.05823 | 24.30 | 75.31 |
| 197 | regulation of endothelial cell proliferation (GO:0001936) | 0.04507 | 0.05823 | 24.30 | 75.31 |
| 198 | regulation of epithelial cell proliferation (GO:0050678) | 0.04555 | 0.05856 | 24.03 | 74.23 |
| 199 | positive regulation of epithelial cell migration (GO:0010634) | 0.04603 | 0.05889 | 23.77 | 73.18 |
| 200 | cellular response to oxygen-containing compound (GO:1901701) | 0.01074 | 0.02708 | 15.32 | 69.45 |
| 201 | positive regulation of protein localization to membrane (GO:1905477) | 0.04938 | 0.06286 | 22.10 | 66.48 |
| 202 | positive regulation of cytokine production (GO:0001819) | 0.01152 | 0.02708 | 14.76 | 65.88 |
| 203 | calcium-mediated signaling (GO:0019722) | 0.04986 | 0.06286 | 21.88 | 65.61 |
| 204 | positive regulation of vasculature development (GO:1904018) | 0.04986 | 0.06286 | 21.88 | 65.61 |
| 205 | regulation of insulin secretion (GO:0050796) | 0.05081 | 0.06376 | 21.45 | 63.92 |
| 206 | activation of GTPase activity (GO:0090630) | 0.05129 | 0.06405 | 21.25 | 63.11 |
| 207 | modulation of chemical synaptic transmission (GO:0050804) | 0.05319 | 0.06607 | 20.45 | 60.01 |
| 208 | regulation of protein kinase activity (GO:0045859) | 0.05367 | 0.06607 | 20.27 | 59.28 |
| 209 | phosphatidylinositol metabolic process (GO:0046488) | 0.05462 | 0.06693 | 19.90 | 57.85 |
| 210 | positive regulation of kinase activity (GO:0033674) | 0.05557 | 0.06778 | 19.54 | 56.49 |
| 211 | positive regulation of protein metabolic process (GO:0051247) | 0.05605 | 0.06804 | 19.37 | 55.82 |
| 212 | positive regulation of angiogenesis (GO:0045766) | 0.05652 | 0.06830 | 19.20 | 55.17 |
| 213 | positive regulation of cell projection organization (GO:0031346) | 0.05700 | 0.06855 | 19.04 | 54.53 |
| 214 | regulation of tumor necrosis factor production (GO:0032680) | 0.06031 | 0.07221 | 17.95 | 50.40 |
| 215 | regulation of protein secretion (GO:0050708) | 0.06078 | 0.07244 | 17.80 | 49.85 |
| 216 | protein localization to plasma membrane (GO:0072659) | 0.06597 | 0.07791 | 16.34 | 44.43 |
| 217 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 0.06597 | 0.07791 | 16.34 | 44.43 |
| 218 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 0.06644 | 0.07811 | 16.22 | 43.98 |
| 219 | protein localization to cell periphery (GO:1990778) | 0.06785 | 0.07941 | 15.87 | 42.69 |
| 220 | positive regulation of transferase activity (GO:0051347) | 0.07160 | 0.08305 | 15.00 | 39.55 |
| 221 | positive regulation of intracellular protein transport (GO:0090316) | 0.07160 | 0.08305 | 15.00 | 39.55 |
| 222 | positive regulation of cell population proliferation (GO:0008284) | 0.02224 | 0.03756 | 10.34 | 39.35 |
| 223 | positive regulation of protein kinase activity (GO:0045860) | 0.07440 | 0.08555 | 14.41 | 37.43 |
| 224 | positive regulation of NF-kappaB transcription factor activity (GO:0051092) | 0.07487 | 0.08570 | 14.31 | 37.10 |
| 225 | peptidyl-serine phosphorylation (GO:0018105) | 0.07533 | 0.08586 | 14.22 | 36.77 |
| 226 | regulation of neuron projection development (GO:0010975) | 0.07952 | 0.09024 | 13.43 | 34.01 |
| 227 | peptidyl-serine modification (GO:0018209) | 0.08138 | 0.09194 | 13.11 | 32.89 |
| 228 | regulation of gene expression (GO:0010468) | 0.01412 | 0.02996 | 7.53 | 32.09 |
| 229 | glycerophospholipid biosynthetic process (GO:0046474) | 0.08508 | 0.09571 | 12.51 | 30.82 |
| 230 | negative regulation of immune response (GO:0050777) | 0.08554 | 0.09582 | 12.44 | 30.58 |
| 231 | negative regulation of macromolecule metabolic process (GO:0010605) | 0.09289 | 0.1036 | 11.40 | 27.08 |
| 232 | protein localization to membrane (GO:0072657) | 0.09335 | 0.1037 | 11.34 | 26.89 |
| 233 | positive regulation of cellular process (GO:0048522) | 0.03715 | 0.05158 | 7.77 | 25.59 |
| 234 | regulation of angiogenesis (GO:0045765) | 0.09701 | 0.1073 | 10.88 | 25.39 |
| 235 | negative regulation of inflammatory response (GO:0050728) | 0.1011 | 0.1109 | 10.42 | 23.87 |
| 236 | phosphate-containing compound metabolic process (GO:0006796) | 0.1011 | 0.1109 | 10.42 | 23.87 |
| 237 | regulation of cell growth (GO:0001558) | 0.1034 | 0.1129 | 10.17 | 23.08 |
| 238 | positive regulation of cell motility (GO:2000147) | 0.1052 | 0.1144 | 9.98 | 22.49 |
| 239 | positive regulation of DNA-binding transcription factor activity (GO:0051091) | 0.1164 | 0.1256 | 8.95 | 19.26 |
| 240 | regulation of cell population proliferation (GO:0042127) | 0.05351 | 0.06607 | 6.31 | 18.47 |
| 241 | positive regulation of cell differentiation (GO:0045597) | 0.1218 | 0.1308 | 8.53 | 17.96 |
| 242 | negative regulation of signal transduction (GO:0009968) | 0.1258 | 0.1345 | 8.24 | 17.08 |
| 243 | regulation of cell cycle (GO:0051726) | 0.1386 | 0.1476 | 7.42 | 14.66 |
| 244 | positive regulation of transcription by RNA polymerase II (GO:0045944) | 0.07274 | 0.08401 | 5.27 | 13.80 |
| 245 | negative regulation of gene expression (GO:0010629) | 0.1499 | 0.1590 | 6.81 | 12.92 |
| 246 | negative regulation of cell population proliferation (GO:0008285) | 0.1742 | 0.1840 | 5.76 | 10.08 |
| 247 | positive regulation of macromolecule metabolic process (GO:0010604) | 0.1763 | 0.1855 | 5.69 | 9.87 |
| 248 | phosphorylation (GO:0016310) | 0.1830 | 0.1918 | 5.46 | 9.27 |
| 249 | transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 0.1846 | 0.1928 | 5.40 | 9.12 |
| 250 | regulation of cell migration (GO:0030334) | 0.1863 | 0.1937 | 5.35 | 8.98 |
| 251 | positive regulation of transcription, DNA-templated (GO:0045893) | 0.1148 | 0.1243 | 3.98 | 8.62 |
| 252 | regulation of nucleic acid-templated transcription (GO:1903506) | 0.1954 | 0.2024 | 5.07 | 8.27 |
| 253 | regulation of cellular macromolecule biosynthetic process (GO:2000112) | 0.2109 | 0.2175 | 4.65 | 7.23 |
| 254 | positive regulation of gene expression (GO:0010628) | 0.2165 | 0.2225 | 4.51 | 6.90 |
| 255 | protein phosphorylation (GO:0006468) | 0.2221 | 0.2273 | 4.38 | 6.58 |
| 256 | positive regulation of nucleic acid-templated transcription (GO:1903508) | 0.2281 | 0.2325 | 4.24 | 6.27 |
| 257 | positive regulation of intracellular signal transduction (GO:1902533) | 0.2418 | 0.2456 | 3.96 | 5.63 |
| 258 | negative regulation of cellular process (GO:0048523) | 0.2496 | 0.2525 | 3.82 | 5.30 |
| 259 | cytokine-mediated signaling pathway (GO:0019221) | 0.2706 | 0.2727 | 3.47 | 4.54 |
| 260 | regulation of transcription by RNA polymerase II (GO:0006357) | 0.3040 | 0.3051 | 2.02 | 2.40 |
| 261 | regulation of transcription, DNA-templated (GO:0006355) | 0.3114 | 0.3114 | 1.98 | 2.31 |
GO: Molecular Function
| Index | Name | P-value | Adjusted p-value | Odds Ratio | Combined score |
| 1 | GDP binding (GO:0019003) | 9.011e-11 | 2.433e-9 | 321.42 | 7434.41 |
| 2 | neurotrophin TRK receptor binding (GO:0005167) | 0.002997 | 0.008990 | 444.11 | 2580.41 |
| 3 | neurotrophin TRKA receptor binding (GO:0005168) | 0.002997 | 0.008990 | 444.11 | 2580.41 |
| 4 | GTP binding (GO:0005525) | 1.733e-8 | 2.283e-7 | 107.64 | 1923.63 |
| 5 | guanyl ribonucleotide binding (GO:0032561) | 3.229e-8 | 2.283e-7 | 94.65 | 1632.51 |
| 6 | GTPase activity (GO:0003924) | 3.383e-8 | 2.283e-7 | 93.74 | 1612.51 |
| 7 | diacylglycerol kinase activity (GO:0004143) | 0.005488 | 0.01482 | 222.00 | 1155.57 |
| 8 | nucleoside-triphosphatase activity (GO:0017111) | 1.192e-7 | 6.434e-7 | 72.22 | 1151.45 |
| 9 | protein kinase C activity (GO:0004697) | 0.006979 | 0.01713 | 170.74 | 847.70 |
| 10 | purine ribonucleoside triphosphate binding (GO:0035639) | 0.000001443 | 0.000006493 | 42.93 | 577.42 |
| 11 | phosphatidylinositol phospholipase C activity (GO:0004435) | 0.01144 | 0.02398 | 100.85 | 450.83 |
| 12 | phospholipase C activity (GO:0004629) | 0.01243 | 0.02398 | 92.44 | 405.55 |
| 13 | SH2 domain binding (GO:0042169) | 0.01589 | 0.02860 | 71.54 | 296.32 |
| 14 | guanyl-nucleotide exchange factor activity (GO:0005085) | 0.002386 | 0.008990 | 33.75 | 203.77 |
| 15 | SH3 domain binding (GO:0017124) | 0.03058 | 0.04587 | 36.30 | 126.60 |
| 16 | phosphotransferase activity, alcohol group as acceptor (GO:0016773) | 0.03688 | 0.05241 | 29.90 | 98.68 |
| 17 | GTPase activator activity (GO:0005096) | 0.01158 | 0.02398 | 14.71 | 65.59 |
| 18 | kinase activity (GO:0016301) | 0.05462 | 0.07145 | 19.90 | 57.85 |
| 19 | phosphatase binding (GO:0019902) | 0.05557 | 0.07145 | 19.54 | 56.49 |
| 20 | protein phosphatase binding (GO:0019903) | 0.05984 | 0.07344 | 18.09 | 50.96 |
| 21 | kinase binding (GO:0019900) | 0.02111 | 0.03562 | 10.64 | 41.04 |
| 22 | protein kinase binding (GO:0019901) | 0.02513 | 0.03991 | 9.67 | 35.61 |
| 23 | zinc ion binding (GO:0008270) | 0.1559 | 0.1739 | 6.52 | 12.12 |
| 24 | protein serine/threonine kinase activity (GO:0004674) | 0.1593 | 0.1739 | 6.36 | 11.69 |
| 25 | calcium ion binding (GO:0005509) | 0.1610 | 0.1739 | 6.29 | 11.49 |
| 26 | transition metal ion binding (GO:0046914) | 0.2015 | 0.2093 | 4.89 | 7.84 |
| 27 | metal ion binding (GO:0046872) | 0.2305 | 0.2305 | 4.19 | 6.15 |
GO: Cellular Component
| Index | Name | P-value | Adjusted p-value | Odds Ratio | Combined score |
| 1 | glutamatergic synapse (GO:0098978) | 0.0005185 | 0.005012 | 74.34 | 562.35 |
| 2 | aggresome (GO:0016235) | 0.01737 | 0.07195 | 65.22 | 264.33 |
| 3 | secretory granule membrane (GO:0030667) | 0.0002842 | 0.005012 | 31.18 | 254.65 |
| 4 | membrane raft (GO:0045121) | 0.002846 | 0.01651 | 30.79 | 180.49 |
| 5 | azurophil granule membrane (GO:0035577) | 0.02863 | 0.1038 | 38.86 | 138.07 |
| 6 | bounding membrane of organelle (GO:0098588) | 0.0003745 | 0.005012 | 16.80 | 132.55 |
| 7 | Golgi membrane (GO:0000139) | 0.001385 | 0.01004 | 17.84 | 117.41 |
| 8 | tertiary granule membrane (GO:0070821) | 0.03591 | 0.1061 | 30.74 | 102.25 |
| 9 | lipid droplet (GO:0005811) | 0.03785 | 0.1061 | 29.11 | 95.32 |
| 10 | plasma membrane raft (GO:0044853) | 0.04026 | 0.1061 | 27.31 | 87.73 |
| 11 | specific granule membrane (GO:0035579) | 0.04459 | 0.1078 | 24.57 | 76.41 |
| 12 | endoplasmic reticulum membrane (GO:0005789) | 0.004470 | 0.02160 | 11.65 | 63.06 |
| 13 | mitochondrial outer membrane (GO:0005741) | 0.06126 | 0.1349 | 17.66 | 49.31 |
| 14 | organelle outer membrane (GO:0031968) | 0.06879 | 0.1349 | 15.64 | 41.87 |
| 15 | azurophil granule (GO:0042582) | 0.07487 | 0.1349 | 14.31 | 37.10 |
| 16 | specific granule (GO:0042581) | 0.07720 | 0.1349 | 13.86 | 35.50 |
| 17 | tertiary granule (GO:0070820) | 0.07906 | 0.1349 | 13.52 | 34.30 |
| 18 | late endosome (GO:0005770) | 0.09060 | 0.1460 | 11.70 | 28.10 |
| 19 | early endosome (GO:0005769) | 0.1253 | 0.1850 | 8.27 | 17.18 |
| 20 | cell-cell junction (GO:0005911) | 0.1276 | 0.1850 | 8.12 | 16.71 |
| 21 | endosome membrane (GO:0010008) | 0.1511 | 0.2021 | 6.74 | 12.74 |
| 22 | lysosomal membrane (GO:0005765) | 0.1533 | 0.2021 | 6.64 | 12.45 |
| 23 | cytoplasmic vesicle membrane (GO:0030659) | 0.1746 | 0.2093 | 5.75 | 10.03 |
| 24 | focal adhesion (GO:0005925) | 0.1775 | 0.2093 | 5.64 | 9.75 |
| 25 | cell-substrate junction (GO:0030055) | 0.1805 | 0.2093 | 5.54 | 9.49 |
| 26 | mitochondrial membrane (GO:0031966) | 0.2113 | 0.2357 | 4.63 | 7.21 |
| 27 | intracellular non-membrane-bounded organelle (GO:0043232) | 0.4493 | 0.4826 | 1.81 | 1.45 |
| 28 | nucleus (GO:0005634) | 0.9211 | 0.9505 | 0.38 | 0.03 |
| 29 | intracellular membrane-bounded organelle (GO:0043231) | 0.9505 | 0.9505 | 0.32 | 0.02 |


